Home Cart Sign in  
Chemical Structure| 1613220-15-7 Chemical Structure| 1613220-15-7

Structure of Niraparib tosylate hydrate
CAS No.: 1613220-15-7

Chemical Structure| 1613220-15-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. It inhibits DNA damage repair, activates apoptosis, and exhibits antitumor activity.

Synonyms: MK-4827 tosylate hydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Niraparib tosylate hydrate

CAS No. :1613220-15-7
Formula : C26H30N4O5S
M.W : 510.61
SMILES Code : O=C(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C12)N.O=S(C5=CC=C(C)C=C5)(O)=O.[H]O[H]
Synonyms :
MK-4827 tosylate hydrate
MDL No. :MFCD28167748
InChI Key :ACNPUCQQZDAPJH-FMOMHUKBSA-N
Pubchem ID :74763937

Safety of Niraparib tosylate hydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H340
Precautionary Statements:P260-P264-P270-P280-P281-P330-P301+P312-P405-P501

Related Pathways of Niraparib tosylate hydrate

epigenetics
DNA

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.96mL

0.39mL

0.20mL

9.79mL

1.96mL

0.98mL

19.58mL

3.92mL

1.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories